Data presented at ICAD-2008 show Suven’s 5-HT6 antagonist SUVN-502 to be effective in preclinical models of Alzheimer’s
Filed under: gpcr | Tagged: 5-ht6, 5ht6, antagonist, Preclinical, Research, suven |
Δ
Leave a comment